Oramed Pharmaceuticals (Israel) Profile

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in Jerusalem, Israel. Oramed Pharmaceuticals is traded on Tel Aviv Stock Exchange in Israel. more
NameOramed Pharmaceuticals
President CEO, DirectorNadav KidronView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business AddressHi-Tech Park 2/4
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
BenchmarkDOW
Websitewww.oramed.com
Phone972 2 566 0001
Next Fiscal Year EndAugust 31, 2019
Most Recent QuarterMay 31, 2018
Last Fiscal Year EndAugust 31, 2017

Oramed Pharmaceuticals Directors

Oramed Pharmaceuticals Corporate Directors

Miriam Kidron Chief Scientific Officer, Director
David Slager Independent Director
Aviad Friedman Independent Director
Additionally take a look at Your Equity Center. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Search macroaxis.com